恶性肿瘤患者术中自体血回输的临床应用进展  

Progress in clinical application of intra-operative cell salvage in patients with malignant tumors

作　　者：王东红[1] 赵永强[2] 李文娟[1] 薛建军 WANG Donghong;ZHAO Yongqiang;LI Wenjuan;XUE Jianjun(Anesthesia and Pain Medical Center,Gansu Provincial Hospital of Traditional Chinese Medicine,Gansu Province,Lanzhou730050,China;Department of Urology,Gansu Provincial Hospital of Traditional Chinese Medicine,Gansu Province,Lanzhou730050,China;Gansu Province Anesthesia Clinical Research Center of Integrated Traditional Chinese and Western Medicine,Gansu Province,Lanzhou730050,China)

机构地区：[1]甘肃省中医院麻醉疼痛医学中心,甘肃兰州730050 [2]甘肃省中医院泌尿外科,甘肃兰州730050 [3]甘肃省中西医结合麻醉临床医学研究中心,甘肃兰州730050

出　　处：《中国医药导报》2023年第12期48-51,共4页China Medical Herald

基　　金：甘肃省科技计划项目临床医学研究中心建设项目(20JR10RA435);甘肃省科技计划项目自然科学基金项目(21JR1RA055);甘肃省卫生健康行业科研计划项目(GSWSHL2020-34)。

摘　　要：随着我国人口老龄化的加剧,恶性肿瘤发病率居高不下,越来越多的恶性肿瘤患者选择手术治疗,使得临床需血量与日俱增。为缓解临床用血的压力,各种血液保护方法层出不穷。术中自体血回输(IOCS)是近年来应用最为广泛、成本效益最高的方法之一,在心脏、创伤等大手术中已经列为常规措施。恶性肿瘤通常具有广泛血供,手术创伤大、出血量多,往往需要输注异体血来保证患者安全,但输注异体血不利于患者预后。所以,近年来IOCS技术在恶性肿瘤患者中应用时有报道,尤其联合白细胞滤器的应用日益增多。本文通过文献整理,就目前恶性肿瘤患者IOCS现状做一综述。With the aggravation of the aging population in China,the incidence rate of malignant tumors remains high.More and more patients with malignant tumors choose surgical treatment,which makes the clinical blood demand increase day by day.In order to relieve the pressure of clinical blood use,various blood protection methods emerge in endlessly.Intra-operative cell salvage(IOCS)is one of the most widely used and cost-effective methods in recent years.It has been listed as a routine measure in major operations such as heart and trauma.Malignant tumors usually have extensive blood supply,large surgical trauma and a large amount of bleeding.Allogeneic blood transfusion is often needed to ensure the safety of patients,but allogeneic blood transfusion is not conducive to the prognosis of patients.Therefore,in recent years,the application of IOCS technology in patients with malignant tumors has been reported,especially the application of combined leukocyte-depleted filter is increasing.This paper reviews the current situation of IOCS in patients with malignant tumors through literature review.

关 键 词：肿瘤 术中自体血回输 临床应用 进展 

分 类 号：R457.1[医药卫生—治疗学]